Jolanta Airey
Patrimonio netto: - $ in data 31/07/2026
Patrimonio netto: - $ in data 31/07/2026
Dr. Jolanta Airey was previously employed as a Chief Medical Officer by Cynata Therapeutics Ltd., a Director-Translational Development by CSL Ltd., and a Head-Clinical Development Physician by CSL Seqirus Inc. She received her doctorate degree from Vilnius University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ACRUX LIMITED | Direttore Tecnico/Scientifico/R&S | 24/08/2026 |
| Società | Posizione | Fine |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Direttore Tecnico/Scientifico/R&S | 01/01/2026 |
| CSL LIMITED | Corporate Officer/Principal | 01/10/2021 |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Acrux Ltd.
Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Vilnius University
Vilnius University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale